William Blair Brokers Reduce Earnings Estimates for Repligen
Repligen Co. (NASDAQ:RGEN – Free Report) – William Blair cut their Q1 2025 earnings per share (EPS) estimates for shares of Repligen in a report issued on Friday, February 21st. William Blair analyst M. Larew now expects that the biotechnology company will post earnings per share of $0.33 for the quarter, down from their previous […]
Repligen Co. (NASDAQ:RGEN – Free Report) – William Blair cut their Q1 2025 earnings per share (EPS) estimates for shares of Repligen in a report issued on Friday, February 21st. William Blair analyst M. Larew now expects that the biotechnology company will post earnings per share of $0.33 for the quarter, down from their previous […]
